insitro
Company ● Covered in 1 story + Follow ✴ AI Graph LinkedIn
This profile is built automatically from TLDRocket coverage.
Signals
1 story (new)
Media momentum
As of 21 Oct 2026 · Visible stories in the last 30 days, compared with the 30 days before.
1 source
Source diversity
As of 21 Oct 2026 · Distinct publications behind this entity's visible coverage.
—
Release activity
As of 21 Oct 2026 · Model, product and open-source release events in the last 90 days whose coverage involves this entity.
—
Funding signals
As of 21 Oct 2026 · Funding and acquisition events in the last 90 days whose coverage involves this entity.
Oct 2026
Coverage span
As of 21 Oct 2026 · First to most recent month of TLDRocket coverage of this entity.
Management
updated 19 Oct 2026- Stephen Meadows Associate Director, Administration | Executive Assistant To The CEO
- Ajamete Kaykas Chief eXploration Officer & Head of Neuroscience
- Erica Lagomarsino Manager, People Operations
- Eric Mckeeby Head of Corporate Communications
- Mary Rozenman CFO & CBO
- Eray Watts VP, High Throughput Chemistry
- Philip Tagari CSO insitro
- Sungjin Lee Director
- Nathan Williams Chief of Staff to the CEO
- Tommy Casolaro Advanced Technology Exploration
- Heiko Runz Vice President for Neuroscience/Genetics
- Eva Czirr Director Biology (neuroscience)
+ 28 more tracked
Latest developments
Q4 2026
AstraZeneca and insitro announce a partnership Partnership
Relationships
Products & technology
- Integrated with insitro’s Virtual Human causal AI platform · 1 source
- Deploys AstraZeneca · 1 source
Partnerships
- AstraZeneca partnered with this company · 1 source